retatrutide phase 2 trial obesity nejm 2023 Dosing Guide: 1-12 mg Weekly Triple Agonist (2026) Retatrutide (not yet approved in
Description
Under physiological conditions, GLP- 1 is rapidly degraded by dipeptidyl peptidase-4 (DPP- 4) after it is released (7)
These are also the ones most studied in pregnancy so far
Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity
Weight loss is not a side effect but the primary endpoint
